BVS

NASDAQ 已收盘

Bioventus

9.95 USD
▼-0.67-6.31%
盘后 10.90 0.00%
2026-11-19
市值
$832.50M
市盈率
12.21
EPS
0.81
股息率
—
52 周区间
6.47 – 15.89
成交量
571.97K
Beta
0.63
目标价
16.60
52W 低 6.4752W 高 15.89
价格走势

公司简介

Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company’s product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to treat chronic peripheral pain, and TalisMann provides stimulation to the targeted peripheral nerve, as well as XCELL PRP System, a ...